RecruitingNCT05939232
Registry of X-linked Adrenoleukodystrophy
Studying X-linked adrenoleukodystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Tiantan Hospital
- Principal Investigator
- Yilong Wang, MD,PhDBeijing Tiantan Hospital, Capital Medical University, Beijing, China
- Enrollment
- 200 enrolled
- Eligibility
- 6-70 years · All sexes
- Timeline
- 2023 – 2028
Study locations (1)
- Beijing Tiantan Hospital, Beijing, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05939232 on ClinicalTrials.govOther trials for X-linked adrenoleukodystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT03727555IT and IV Lentiviral Gene Therapy for X-ALDShenzhen Geno-Immune Medical Institute
- RECRUITINGNCT06178120Disease Progression in Women With X-linked AdrenoleukodystrophyMinoryx Therapeutics, S.L.
- RECRUITINGNCT04675749Quality of Life in Women with X-linked AdrenoleukodystrophyLeipzig University Medical Center